12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers
Mustang Bio (NASDAQ:MBIO) shares rose 6.9% to $1.39 during Friday's after-market session. The company's market cap stands at $129.8 million.
Aileron Therapeutics Provides Business Update And Outlines 2022 Strategic Priorities To Deliver Key Milestones
Plans to initiate Phase 1b clinical trial of ALRN-6924 in neoadjuvant breast cancer in 1H22; interim results expected in 4Q22
Planned readouts for ongoing randomized, double-blind, placebo-controlled non-small cell
Aileron Therapeutics Presents Data At AACR-NCI-EORTC International Conference Demonstrating ALRN-6924’s Activity As Radioprotective Agent In Preclinical Models Of Acute Radiation-Induced Toxicity
Aileron Therapeutics (NASDAQ:ALRN), a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patients, today presented new preclinical data at the AACR-NCI-EORTC
Aileron Therapeutics Announces Presentation of New Preclinical Data at Upcoming AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2021
Aileron Therapeutics (NASDAQ:ALRN), a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patients, today announced it will present new preclinical data at the
Aileron Stock Is Trading Lower After Data Presentation For Chemoprotective Agent
Aileron Therapeutics Inc (NASDAQ:ALRN) presented new clinical data at the European Society of Medical Oncology (ESMO21) Virtual Congress 2021 for ALRN-6924,…